David Macdonald
Stock Analyst at Truist Securities
(4.02)
# 537
Out of 5,134 analysts
325
Total ratings
59.14%
Success rate
8.86%
Average return
Main Sectors:
Stocks Rated by David Macdonald
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CI The Cigna Group | Reiterates: Buy | $320 → $350 | $293.28 | +19.34% | 13 | Feb 17, 2026 | |
| MOH Molina Healthcare | Maintains: Hold | $190 → $145 | $135.27 | +7.19% | 16 | Feb 17, 2026 | |
| HUM Humana | Maintains: Hold | $285 → $200 | $186.01 | +7.52% | 17 | Feb 17, 2026 | |
| DGX Quest Diagnostics | Maintains: Hold | $205 → $220 | $204.50 | +7.58% | 16 | Feb 11, 2026 | |
| ENSG The Ensign Group | Maintains: Hold | $200 → $215 | $214.94 | +0.03% | 19 | Feb 6, 2026 | |
| UNH UnitedHealth Group | Maintains: Buy | $410 → $370 | $292.29 | +26.59% | 24 | Feb 2, 2026 | |
| ELV Elevance Health | Maintains: Buy | $400 → $390 | $345.45 | +12.90% | 8 | Feb 2, 2026 | |
| HCA HCA Healthcare | Maintains: Buy | $520 → $546 | $536.69 | +1.73% | 18 | Jan 28, 2026 | |
| CVS CVS Health | Maintains: Buy | $95 → $98 | $78.44 | +24.94% | 15 | Dec 10, 2025 | |
| PNTG The Pennant Group | Upgrades: Buy | $28 → $34 | $31.37 | +8.38% | 17 | Dec 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $34 | $32.46 | +4.74% | 6 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $13 | $9.84 | +32.11% | 4 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $81 → $90 | $70.50 | +27.66% | 12 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $17 → $24 | $21.76 | +10.32% | 17 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $9.5 → $10 | $7.63 | +31.06% | 9 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $225 → $240 | $232.09 | +3.41% | 22 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 → $45 | $41.47 | +8.51% | 5 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $140 | $111.84 | +25.18% | 13 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $290 → $310 | $272.69 | +13.68% | 7 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $3.5 → $4.25 | $3.47 | +22.66% | 8 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $170 → $164 | $152.01 | +7.89% | 19 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $25 → $30 | $24.61 | +21.90% | 15 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $13 | $10.40 | +25.00% | 12 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $32 | $41.09 | -22.12% | 6 | Jan 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $34 | $35.62 | -4.55% | 2 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $29 | $23.54 | +23.22% | 1 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $48 | $22.22 | +116.02% | 3 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $33 | $0.35 | +9,232.58% | 1 | Jul 14, 2022 |
The Cigna Group
Feb 17, 2026
Reiterates: Buy
Price Target: $320 → $350
Current: $293.28
Upside: +19.34%
Molina Healthcare
Feb 17, 2026
Maintains: Hold
Price Target: $190 → $145
Current: $135.27
Upside: +7.19%
Humana
Feb 17, 2026
Maintains: Hold
Price Target: $285 → $200
Current: $186.01
Upside: +7.52%
Quest Diagnostics
Feb 11, 2026
Maintains: Hold
Price Target: $205 → $220
Current: $204.50
Upside: +7.58%
The Ensign Group
Feb 6, 2026
Maintains: Hold
Price Target: $200 → $215
Current: $214.94
Upside: +0.03%
UnitedHealth Group
Feb 2, 2026
Maintains: Buy
Price Target: $410 → $370
Current: $292.29
Upside: +26.59%
Elevance Health
Feb 2, 2026
Maintains: Buy
Price Target: $400 → $390
Current: $345.45
Upside: +12.90%
HCA Healthcare
Jan 28, 2026
Maintains: Buy
Price Target: $520 → $546
Current: $536.69
Upside: +1.73%
CVS Health
Dec 10, 2025
Maintains: Buy
Price Target: $95 → $98
Current: $78.44
Upside: +24.94%
The Pennant Group
Dec 2, 2025
Upgrades: Buy
Price Target: $28 → $34
Current: $31.37
Upside: +8.38%
Nov 14, 2025
Maintains: Buy
Price Target: $30 → $34
Current: $32.46
Upside: +4.74%
Nov 14, 2025
Maintains: Buy
Price Target: $21 → $13
Current: $9.84
Upside: +32.11%
Nov 12, 2025
Maintains: Buy
Price Target: $81 → $90
Current: $70.50
Upside: +27.66%
Nov 10, 2025
Maintains: Hold
Price Target: $17 → $24
Current: $21.76
Upside: +10.32%
Nov 7, 2025
Maintains: Hold
Price Target: $9.5 → $10
Current: $7.63
Upside: +31.06%
Nov 3, 2025
Reiterates: Buy
Price Target: $225 → $240
Current: $232.09
Upside: +3.41%
Oct 30, 2025
Reiterates: Buy
Price Target: $42 → $45
Current: $41.47
Upside: +8.51%
Aug 14, 2025
Maintains: Buy
Price Target: $135 → $140
Current: $111.84
Upside: +25.18%
Jul 25, 2025
Maintains: Buy
Price Target: $290 → $310
Current: $272.69
Upside: +13.68%
Jul 16, 2025
Maintains: Hold
Price Target: $3.5 → $4.25
Current: $3.47
Upside: +22.66%
May 19, 2025
Maintains: Hold
Price Target: $170 → $164
Current: $152.01
Upside: +7.89%
May 12, 2025
Maintains: Hold
Price Target: $25 → $30
Current: $24.61
Upside: +21.90%
May 12, 2025
Maintains: Buy
Price Target: $14 → $13
Current: $10.40
Upside: +25.00%
Jan 6, 2025
Maintains: Buy
Price Target: $46 → $32
Current: $41.09
Upside: -22.12%
Nov 1, 2024
Maintains: Buy
Price Target: $41 → $34
Current: $35.62
Upside: -4.55%
Aug 19, 2024
Initiates: Buy
Price Target: $29
Current: $23.54
Upside: +23.22%
Aug 12, 2022
Maintains: Buy
Price Target: $40 → $48
Current: $22.22
Upside: +116.02%
Jul 14, 2022
Maintains: Buy
Price Target: $30 → $33
Current: $0.35
Upside: +9,232.58%